This situation has concluded
It was preserved as a record on September 4; the timeline below shows how it unfolded, with sources. Get the briefing to follow the top situations still developing: three emails a week, sourced and in order.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
4 clusters · 47 sources · 9 days · First seen · Last updated
US talc litigation: J&J $5.5B settlement
Overview
U.S. courts continue to hear large talc lawsuits alleging asbestos in baby powder caused ovarian cancer and mesothelioma. A California jury awarded $966 million to a mesothelioma patient, and manufacturers have set aside roughly $9 billion for liability. The litigation prompted removal of talc baby‑powder from U.S. and Canadian markets in 2020; J&J stopped selling talc‑based baby powder in the United States in 2020 and worldwide in 2023.
Researchers have highlighted tumor risks from injectable contraceptives, linking long‑term high‑dose use to meningiomas, fueling calls for stronger safety standards for women’s products.
In July 2026 Johnson & Johnson announced a voluntary settlement valued at about $5.5 billion to resolve roughly 76,000 ovarian‑cancer claims. The plan requires at least 95 % of eligible claimants to accept; $3 billion would be paid in 2027 with the balance in 2028. J&J maintains its talc is asbestos‑free, does not admit liability, and its litigation vice‑president called the claims “baseless.” The settlement, negotiated outside bankruptcy court, covers only existing suits and would resolve the claims within 18‑24 months if the acceptance threshold is met.
Entities
Johnson & Johnson · Erik Haas · Chris Seeger · US federal courts · U.S. District Court for the District of New Jersey
Claims
What the coverage asserts, and how many sources carry each claim.
- [● 13 SOURCES] Johnson & Johnson will pay an estimated $5.5 billion to settle talc lawsuits.
- [● 11 SOURCES] The settlement aims to resolve about 76,000 ovarian‑cancer claims.
- [● 11 SOURCES] The settlement requires participation of at least 95 % of eligible claimants to proceed.
- [● 11 SOURCES] The settlement is voluntary and negotiated outside bankruptcy court.
- [● 11 SOURCES] Johnson & Johnson will make an initial $3 billion payment in 2027, with the remainder paid by 2028.
- [● 11 SOURCES] Johnson & Johnson maintains its talc products are safe and asbestos‑free, denying a causal link to cancer.
- [● 11 SOURCES] Three prior attempts to resolve the talc litigation through bankruptcy were rejected by U.S. courts.
- [● 11 SOURCES] The settlement does not cover future talc‑related lawsuits.
- [● 9 SOURCES] Johnson & Johnson offered a $5.5 billion settlement to resolve talc cancer lawsuits.
- [● 6 SOURCES] Johnson & Johnson agreed to pay at least $5.5 billion to settle talc‑related lawsuits.
- [● 6 SOURCES] The settlement is expected to resolve claims within 18–24 months.
- [● 6 SOURCES] Johnson & Johnson agreed to pay at least $5.5 billion to settle talc lawsuits.
- [● 3 SOURCES] The settlement requires at least 95 % of eligible claimants to participate.
- [● 3 SOURCES] The settlement is voluntary and not filed through bankruptcy court.
- [● 3 SOURCES] Johnson & Johnson previously attempted three bankruptcy filings to resolve the talc litigation, all of which were rejected by US courts.
- [● 3 SOURCES] The settlement would cover approximately 76,000 ovarian‑cancer claims.
- [● 3 SOURCES] The settlement requires at least 95 % participation of eligible claimants to become effective.
- [● 3 SOURCES] The settlement is voluntary and was negotiated outside of bankruptcy court.
- [● 2 SOURCES] The settlement covers about 76,000 claims, including federal court cases in New Jersey and related state‑court actions.
- [● 2 SOURCES] The settlement requires acceptance by 95% of ovarian‑cancer claimants before it becomes final.
- [● 2 SOURCES] Johnson & Johnson expects to pay $3 billion in 2027 with further payments in 2028.
- [● 2 SOURCES] Total payout could exceed $7 billion depending on participation levels.
- [● 2 SOURCES] Johnson & Johnson previously settled most asbestos‑related talc lawsuits alleging mesothelioma.
- [● 2 SOURCES] Erik Haas, J&J’s vice president of litigation, said the claims are meritless.
- [● 2 SOURCES] Chris Seeger, representing about 2,500 clients, said the settlement is fair.
- [● 2 SOURCES] The settlement covers only existing claims, not future lawsuits.
- [● 2 SOURCES] Johnson & Johnson maintains that its talc products are safe and asbestos‑free, denying any link to cancer.
- [● 2 SOURCES] The settlement aims to resolve all existing claims within about 18 months.
- [● 2 SOURCES] Johnson & Johnson maintains its talc products are safe and asbestos‑free, denying causation of ovarian cancer.
- [○ 1 SOURCE] Johnson & Johnson will make an initial $3 billion payment next year, with the balance paid by 2028.
- [○ 1 SOURCE] Johnson & Johnson will make an initial $3 billion payment next year, with no further payments before 2028.
Timeline
-
[BUSINESS] 3 sourcesJohnson & Johnson offers $5.5 billion settlement to end talc lawsuits
Johnson & Johnson proposes a $5.5 billion settlement covering about 76,000 talc lawsuits, denying liability and awaiting approval from plaintiffs’ counsel.
-
[BUSINESS] 11 sourcesJohnson & Johnson proposes $5.5 billion settlement to end talc cancer lawsuits
Johnson & Johnson offers a $5.5 billion voluntary settlement covering ~76,000 U.S. ovarian‑cancer talc claims, requiring 95% claimant approval, with $3 billion due in 2027 and the rest in 2028.
-
[BUSINESS] 32 sourcesJohnson & Johnson to Pay $5.5 B to Settle U.S. Talc Cancer Lawsuits
Johnson & Johnson will pay about $5.5 billion to settle 76,000 U.S. talc lawsuits, pending 95% claimant approval; total payout may exceed $7 billion.
-
[HEALTH] 2 sourcesUS Talc Lawsuits and Birth‑Control Risks Highlight Women's Product Safety
US courts award $966 million in a talc baby‑powder case and highlight ongoing lawsuits, while studies link injectable birth‑control to meningioma risk, prompting calls for stricter product safety.
Sources
ageas.com · atvbl.rs · bilkulonline.com · borsaefinanza.it · brasil.elpais.com · brasilemfolhas.com · cash.at · ct24.cz · dnyuz.com · euroweeklynews.com · fashionbiznes.pl · femtechworld.co.uk · finanse.wp.pl · folhadoprogresso.com.br · gamereactor.de · gamereactor.no · gamereactor.pl · gamereactor.se · ibtimes.com.au · insidefmcg.com.au · internewscast.com · it-boltwise.de · moj.powiat.pl · muzejrudarstvaimetalurgije.org · n1info.hr · ndmais.com.br · nenoticias.com.br · newswire.lk · nypost.com · op-online.de · orissapost.com · railwaysimulator.com · ratb.ro · sapo.pt · seucreditodigital.com.br · sokolovelaw.com · superbiz.se.pl · theartscouncil.com · thecurrent.pk · thefrontierpost.com · thethinkingconservative.com · usa.inquirer.net · usanews.net · vandringen.se · wiadomoscikosmetyczne.pl · wvfm1065.com · yovenice.com
This summary has been updated 7 times: see revision history